ETF PRO AIOctober 27, 2026
PBE Invesco Dynamic Biotechnology & Genome ETF
Fund tearsheet · data as of the latest session · October 27, 2026
ONE YEAR OF DAILY CLOSES
0.58%expense ratio
$429Mfund assets
+20.8%return, YTD
—return, 1 year
−$960Knet flow, 1 month
+$113Mnet flow, 1 year
19.8%realized volatility, 1y
-11.8%worst drawdown, 1y
Top ten holdings
| 1 | ILMN ILLUMINA | 5.99% |
| 2 | NTRA NATERA | 6.00% |
| 3 | BIIB BIOGEN | 5.68% |
| 4 | GILD GILEAD SCIENCES | 5.24% |
| 5 | RPRX ROYALTY PHARMA | 5.14% |
| 6 | AMGN AMGEN | 4.96% |
| 7 | REGN REGENERON PHARMACEUTICALS | 4.83% |
| 8 | VRTX VERTEX PHARMACEUTICALS | 4.74% |
| 9 | MRNA MODERNA | 3.43% |
| 10 | HALO HALOZYME THERAPEUTICS | 3.13% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS